VirTech Bio, Inc.
Natick, MA, US· latest recorded location
VirTech Bio, Inc. is named on 2 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 2
- Published applications
- 4
- Inventors
- 2
- Granted in 2026 so far
- 1
- Most recent grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 6 documents
Recent patents
- Blood substitutes comprising hemoglobin and methods of making24 Mar 2026US 12,582,703 B2
- Blood substitutes comprising hemoglobin and methods of making22 Nov 2022US 11,504,417 B2
- Compositions and Methods for Treating Hemorrhagic Shock3 Aug 2023US 2023/0241184 A1
- Blood substitutes comprising hemoglobin and methogs of making23 Mar 2023US 2023/0090172 A1
- Oxygenation media for ex-vivo preservation of organs and tissues18 Nov 2021US 2021/0352887 A1
- Blood substitutes comprising hemoglobin and methods of making16 Jul 2020US 2020/0222510 A1
Most cited
By later US patents